Evaluation of the Office on Violence Against Women's Domestic Violence Homicide Prevention Demonstrative Initiative

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2014 by Yale University
Information provided by (Responsible Party):
Yale University
ClinicalTrials.gov Identifier:
First received: December 12, 2013
Last updated: July 8, 2014
Last verified: July 2014

The purpose of this project is to evaluate the Office on Violence Against Women's (OVW) Domestic Violence Homicide Prevention Demonstration Initiative.

Domestic Violence.

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Evaluation of the Domestic Violence Homicide Prevention Initiative

Resource links provided by NLM:

Further study details as provided by Yale University:

Primary Outcome Measures:
  • reductions in DV homicides [ Time Frame: up to 4 years ] [ Designated as safety issue: Yes ]
    Whether there were reductions in DV homicides

Secondary Outcome Measures:
  • Near Lethality [ Time Frame: up to 4 years ] [ Designated as safety issue: Yes ]
    Attempting to suffocate, drown, beat to death (left for dead) blunt instrument like a bat. Also simply like someone charged with attempted murder as the most serious charge. Mainly police reports, supplemarely materials like newspaper, ER reports

Other Outcome Measures:
  • Collateral Killing [ Time Frame: up to 4 years ] [ Designated as safety issue: Yes ]
    people that killed beyond the focal victim mainly police reports. materials like newspaper, ER reports

Study Start Date: January 2014
Estimated Study Completion Date: December 2017
Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)
Contra Costa County, California
Miami-Dade County, Flordia
Palm Beach County, Flordia
Rockdale County, Georgia
Winnebago County, lIlinois
Boston, Massachusetts
Brooklyn, New York
Westchester County, New York
Pitt County, North Carolina
Cuyahoga County, Ohio
North Charleston, South Carolina
Rutland, Vermont

Detailed Description:

During Phase I, 12 sites assessed their structures and processes for addressing domestic violence. In Phase II, up to six sites will implement their work plans to test changes to existing procedures, practices, and structures related to domestic violence homicide prevention. This evaluation will assess the processes and outcomes within and across sites.


As this is an evaluation of models carried out by Phase II sites, the "subjects" are the six funded sites. Research Design and Methods: The national evaluation will be a utilization-focused developmental evaluation-"utilization-focused" in that the project will be done for and with primary intended users of the evaluation findings; "developmental" in that the intended use is development of domestic violence homicide prevention models. Process evaluation will focus on the internal dynamics and actual operations of domestic violence homicide prevention programs at Phase II sites. This will be achieved primarily through the use of system dynamics modeling, which uses computer simulation to understand the behavior of complex systems over time. Outcome evaluation will examine the intended and unintended consequences of the prevention programs. This will be carried out largely through the use of multilevel modeling, which takes into account multiple sources of variation when estimating differences in outcomes between sites.


System dynamics modeling within and across sites will progress through a series of iterative steps involving problem articulation, formulation of a dynamic hypothesis, development of a computer simulation model, validation and model testing, and policy design and recommendations. Multilevel modeling will take into account individual- (victims and perpetrators), intimate partner relationship-, and site-level variables in estimation of between site variation in outcomes. Cost-effectiveness analyses will include an assessment of the cost-effectiveness of the overall initiative, as well as sub-analyses comparing cost-effectiveness of individual sites whose prevention programs proved effective.

Products, Reports, and Data Archiving:

The investigators will produce a final report providing a comprehensive overview of the national evaluation and its findings. The investigators will also provide quarterly financial reports as well as semi-annual progress reports. The final project submission will also include data files with original and transformed data variables; statistical analysis software syntax that documents the analysis process; files that document the system dynamics models; and a data and research guidebook as specified in the archiving plan.


Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

The sites will vary by demographic composition (e.g., race, class, gender, rural-urban-suburban geography, family and community violence rates, resources, political and social systems). We will need to measure the population of subjects involved in the program being evaluated and to determine for whom the program is appropriate. A more specific definition for operationalization of DV homicide, potential perpetrators and victims will be required to make this assessment.


Inclusion Criteria: The demonstration sites are:

  • Contra Costa County, Calif.;
  • Miami-Dade County, Fla.;
  • Palm Beach County, Fla.;
  • Rockdale County, Ga.;
  • Winnebago County, Ill.;
  • Boston, MA;
  • Brooklyn, N.Y.;
  • Westchester County, N.Y.;
  • Pitt County, N.C.;
  • Cuyahoga County, Ohio;
  • North Charleston, S.C.;
  • Rutland, Vt.

    • After the 12-month assessment phase, up to six of the demonstration sites will be selected to continue a three-year implementation phase.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02021838

Contact: Christal M Esposito 203-737-3313 christal.esposito@yale.edu

United States, Connecticut
Yale University Recruiting
New Haven, Connecticut, United States, 06513
Contact: Christal M Esposito    203-737-3313    christal.esposito@yale.edu   
Sponsors and Collaborators
Yale University
Principal Investigator: Lori A Post, PhD Yale University
  More Information

No publications provided

Responsible Party: Yale University
ClinicalTrials.gov Identifier: NCT02021838     History of Changes
Other Study ID Numbers: ZD-CX-0001
Study First Received: December 12, 2013
Last Updated: July 8, 2014
Health Authority: United States: Federal Government

Keywords provided by Yale University:
domestic violence homicide prevention

ClinicalTrials.gov processed this record on March 30, 2015